Pre-Market Review: Boston Scientific Corp., Abbott Laboratories, Zimmer Holdings Inc., and EnteroMedics Inc.

   Pre-Market Review: Boston Scientific Corp., Abbott Laboratories, Zimmer
                     Holdings Inc., and EnteroMedics Inc.

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

LONDON, October 18, 2013

LONDON, October 18, 2013 /PRNewswire/ --

On Thursday, October 17, 2013, the S&P 500 ended the day at 1,733.15, up
0.67%; the Dow Jones Industrial Average closed at 15,371.65, down 0.01%; while
the NASDAQ Composite finished at 3,863.15, up 0.62%. Shares in the medical
appliances and equipment industry mostly ended on a higher note, even as the
broader market fluctuated between gains and losses. The major movers in the
industry included Boston Scientific Corporation (NYSE: BSX), Abbott
Laboratories (NYSE: ABT), Zimmer Holdings Inc. (NYSE: ZMH), and EnteroMedics
Inc. (NASDAQ: ETRM). AAAResearchReports.com initiated preliminary technical
research on BSX, ABT, ZMH, and ETRM. These free reports are accessible by
signing today at:

http://www.aaaresearchreports.com/register/ 

On Thursday, shares in Boston Scientific Corp. ended the day at the previous
day's closing price of $12.38, after hitting a new 52-week high of $12.48. A
total of 12.41 million shares were traded, which is below the daily average
volume of 15.34 million. The company's shares have gained 4.03% in the last
one month and 29.77% in the previous three months, outperforming the S&P 500
which has gained 1.67% and 3.11% during the respective periods. Furthermore,
Boston Scientific Corp.'s stock is trading above its 50-day and 200-day moving
averages of $11.48 and $9.03, respectively. The free technical analysis on BSX
is available by signing up at:

www.AAAResearchReports.com/BSX101813.pdf

Abbott Laboratories' stock surged on Thursday, extending the gains from the
previous trading session. The company's shares closed the day 3.54% higher at
$37.17, after oscillating between $35.89 and $37.27. A total of 17.35 million
shares were traded, which is significantly above the daily average volume of
7.47 million. The company's shares have surged 9.32% in the previous three
trading sessions and 6.29% in the last one month, outperforming the S&P 500
which has gained 1.35% and 1.67% during the respective periods. Additionally,
Abbott Laboratories' stock is trading above its 50-day and 200-day moving
averages of $34.38 and $35.15, respectively. Register now to download free
research on ABT at:

www.AAAResearchReports.com/ABT101813.pdf 

On Thursday, Zimmer Holdings Inc.'s stock closed at $87.88, up 0.18% from the
previous day's closing price of $87.72. The company's shares vacillated
between $87.19 and $87.95 during the trading session. A total of 0.84 million
shares were traded, which is below the daily average volume of 1.03 million.
The company's shares have gained 5.69% in the last one month and 7.59% in the
previous three months, compared to a gain of 1.67% and 3.11% in the S&P 500
during the respective periods. Moreover, Zimmer Holdings Inc.'s stock is
trading near its 52-week high of $88.19 and above its 50-day and 200-day
moving averages of $82.02 and $77.81, respectively. A free report on ZMH can
be accessed by registering at:

www.AAAResearchReports.com/ZMH101813.pdf

EnteroMedics Inc.'s stock plummeted on Thursday, reversing all the gains from
the previous trading session. The company's shares ended the day 2.61% lower
at $1.49, after fluctuating between $1.47 and $1.56. A total of 0.99 million
shares were traded, which is below the daily average volume of 1.04 million.
Despite Thursday's losses, ANN INC.'s stock has surged 19.20% in the last one
month and 41.90% in the previous three months, outperforming the S&P 500 which
has gained 1.67% and 3.11% during the respective periods. Further,
EnteroMedics Inc.'s stock is trading above its 50-day and 200-day moving
averages of $1.17 and $1.28, respectively. Register with
AAAResearchReports.com and download research on ETRM for free at:

www.AAAResearchReports.com/ETRM101813.pdf

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

SOURCE AAA Research Reports

Contact: Peter F. Jones; + 1 (646) 396-9126 (North America);
info@aaaresearchreports.com